GÜMÜŞLÜ, S. 2012. Side effects and clinical course of omalizumab in patients with severe persistent asthma. 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , (Geneva, Switzerland), 452-453.

GÜMÜŞLÜ, S., (2012). Side effects and clinical course of omalizumab in patients with severe persistent asthma . 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) (pp.452-453). Geneva, Switzerland

GÜMÜŞLÜ, SAADET. "Side effects and clinical course of omalizumab in patients with severe persistent asthma," 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Geneva, Switzerland, 2012

GÜMÜŞLÜ, SAADET. "Side effects and clinical course of omalizumab in patients with severe persistent asthma." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, pp.452-453, 2012

GÜMÜŞLÜ, S. (2012) . "Side effects and clinical course of omalizumab in patients with severe persistent asthma." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, pp.452-453.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Side effects and clinical course of omalizumab in patients with severe persistent asthma}, congress name={31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={452-453} }